Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Chinese Patent Office
Argus Health
Boehringer Ingelheim
Queensland Health

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,120,752

« Back to Dashboard

Which drugs does patent 6,120,752 protect, and when does it expire?

Patent 6,120,752 protects ZETONNA and ALVESCO and is included in two NDAs.

This patent has forty-one patent family members in twenty-seven countries.

Summary for Patent: 6,120,752

Title: Medicinal aerosol products containing formulations of ciclesonide and related steroids
Abstract:A pharmaceutical aerosol formulation suitable for oral and/or nasal inhalation including an anti-inflammatory steroid of the formula ##STR1## in which: R.sub.1 is 1-butyl, 2-butyl, cyclohexyl or phenyl and R.sub.2 is acetyl or isobutanoyl, in particular ciclesonide. The formulations also include hydrofluorocarbon propellants such as HFC 134a and/or 227, and cosolvent such as ethanol in an amount sufficient to solubilize the ciclesonide or related steroid (and various optional ingredients, such as surfactant). The formulations exhibit very desirable physical and chemical stability, as well as excellent delivery characteristics.
Inventor(s): Oliver; Martin J. (Clarendon Park, GB), Fatania; Kanu M. (Loughborough, GB), Scott; John S. (Loughborough, GB), Muller; Helgert (Radolfzell, DE)
Assignee: 3M Innovative Properties Company (St. Paul, MN) Byk Gulden Lomberg Chemische Fabrik GmbH (Konstanz, DE)
Application Number:09/076,958
Patent Claim Types:
see list of patent claims
Formulation; Compound; Delivery; Device; Composition;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Astrazeneca Pharms
AEROSOL, METERED;NASAL202129-001Jan 20, 2012RXYesYes► Subscribe► SubscribeY
Astrazeneca Pharms
AEROSOL, METERED;INHALATION021658-002Jan 10, 2008RXYesYes► Subscribe► SubscribeY
Astrazeneca Pharms
AEROSOL, METERED;INHALATION021658-003Jan 10, 2008RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,120,752

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9710496May 21, 1997
United Kingdom9803990Feb 25, 1998

International Patent Family for Patent: 6,120,752

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Turkey9902863► Subscribe
Slovakia283930► Subscribe
Slovakia157699► Subscribe
Slovenia0983058► Subscribe
Serbia49628► Subscribe
Yugoslavia59899► Subscribe
Norway2009024► Subscribe
New Zealand500874► Subscribe
Poland336885► Subscribe
European Patent Office0983058► SubscribeCA 2005 00036Denmark► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Boehringer Ingelheim
Express Scripts
Johnson and Johnson
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus